<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095546</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00658; pk19Zimmermann</org_study_id>
    <nct_id>NCT04095546</nct_id>
  </id_info>
  <brief_title>Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology</brief_title>
  <official_title>Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Leading House for the Latin American Region (Seed Money Grant SMG 1730)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The link between epigenetic changes as an effect of psychotherapy has been investigated&#xD;
      recently. Genes investigated in these studies were brain-derived neurotrophic factor (BDNF),&#xD;
      NR3C1, FKBP51, MAOA and GLUT1. Change in methylation of these genes could be a biomolecular&#xD;
      mechanism of psychotherapy induced changes. This study project aims at providing evidence for&#xD;
      a biological mechanism of personality disorder interventions in adolescence by investigating&#xD;
      the link between epigenetic changes as an effect of psychotherapy. It investigates the&#xD;
      correlation between changes in the methylation of the FKBP5 gene and psychotherapy induced&#xD;
      changes in symptoms and functioning.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    personal changes in study team&#xD;
  </why_stopped>
  <start_date type="Anticipated">April 2022</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">February 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in methylation of the FKBP5 gene</measure>
    <time_frame>after 6 months from baseline</time_frame>
    <description>change in methylation of the FKBP5 gene</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in methylation of the FKBP5 gene</measure>
    <time_frame>at month 3 and at month 12 after baseline.</time_frame>
    <description>change in methylation of the FKBP5 gene</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Borderline Personality Disorder (BPD)</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>routine psychotherapy for Borderline Personality Disorder (BPD)</intervention_name>
    <description>Routine psychotherapy as treatment for patients with Borderline Personality Disorder</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in Basel/ Switzerland will be recruited from the routine clinical practice of the&#xD;
        Outpatient Department of the Child and Adolescent Psychiatric Hospital.&#xD;
&#xD;
        Patients in Santiago/ Chile will be recruited from the Department of Psychiatry and Mental&#xD;
        Health, East Campus,Faculty of Medicine, University of Chile.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adolescents presenting 3 or more criteria for BPD in the Structured clinical interview&#xD;
             for the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) axis II&#xD;
             personality disorders (SCID-II)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  difficulties to understand or comply with instructions&#xD;
&#xD;
          -  psychotic disorders&#xD;
&#xD;
          -  pervasive developmental disorders&#xD;
&#xD;
          -  severe somatic or neurological disorders&#xD;
&#xD;
          -  severe and persistent substance addiction&#xD;
&#xD;
          -  elevated risk for complications related to blood sampling&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronan Zimmermann, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kinder- und Jugendpsychiatrische Klinik/Universit√§re Psychiatrische Klinken Basel (UPK)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Mental Health, East Campus,</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Child and Adolescent Psychiatric Hospital, University Psychiatric Hospitals of the University of Basel</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epigenetic changes</keyword>
  <keyword>Psychotherapy</keyword>
  <keyword>epigenetic regulation</keyword>
  <keyword>methylation patterns</keyword>
  <keyword>change in methylation of genes</keyword>
  <keyword>FKBP5 gene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

